<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ETERNA THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Fri, 10 Apr 2026 18:21:42 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/eterna%5Ftherapeutics%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>ETERNA THERAPEUTICS RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>/C O R R E C T I O N -- Cellipont Bioservices/</title><pubDate>Wed, 29 Oct 2025 15:33:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-cellipont-bioservices-15140322</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml">In the news release, Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer, issued <span class="xn-chron">Oct. 29,  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-cellipont-bioservices-15140322</guid></item><item><title>Cellipont Bioservices and Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership to Advance ERNA-101 Toward Clinical Trials in Ovarian Cancer</title><pubDate>Wed, 29 Oct 2025 13:33:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/cellipont-bioservices-and-ernexa-therapeutics-enter-cell-therapy-manufacturing-partnership-to-advance-erna-101-toward-clinical-trials-in-ovarian-cancer-15139503</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">THE WOODLANDS, Texas, and <span class="xn-location">CAMBRIDGE, Mass., <span class="legendSpanClass"><span class="xn-chron">Oct. 29, 2025 /PRNewswire/ -- <u><a  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/cellipont-bioservices-and-ernexa-therapeutics-enter-cell-therapy-manufacturing-partnership-to-advance-erna-101-toward-clinical-trials-in-ovarian-cancer-15139503</guid></item></channel></rss>
